- Latest news▼
-
15:32, April 26 ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic
-
08:43, April 26 Enzymes that convert different blood groups into first group are discovered
-
19:41, April 25 Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
-
17:31, April 25 JAMA: patient grew long, curly eyelashes because of chemotherapy
-
11:08, April 25 Mpox epidemic declared in Republic of the Congo
-
08:31, April 25 OU: quitting smoking 4 times more likely to cure laryngeal cancer
-
01:20, April 25 Paralyzed man in China writes hieroglyphs using neural implants placed in his brain
-
15:11, April 24 Zombie deer disease possibly linked to hunters’ deaths
-
12:27, April 23 Appetite: Scientists found out the secret to the appeal of large portions of fast food
-
10:33, April 23 Scientists test new approach to fighting viruses
-
08:38, April 23 Ketamine may help with postpartum depression
-
22:12, April 22 Unhealthy amount of sugar found in baby food products of a well-known brand
-
19:41, April 22 Air pollution puts health of more than 1.6 billion workers globally at risk
-
17:25, April 22 Scientists found baked goods and lack of sleep to be more dangerous than alcohol
-
16:02, April 22 342 cases of measles recorded in Armenia so far in 2024
All materials
Hydroxychloroquine used to treat COVID-19 can be dangerous, study claims
Hydroxychloroquine is not only not effective against coronavirus infection, but can also be dangerous for the body due to side effects that it can provoke, shine.cn reported referring to a new study.
Scientists have recognized that hydroxychloroquine may contribute slightly to healing and reducing symptoms of COVID-19 infection, but brought more complications.
The research conducted by Ruijin Hospital studied 150 COVID-19 patients recruited from 16 Chinese hospitals between February 11 and March 20. And patients were divided into two groups: one with hydroxychloroquine plus standard care and one with standard care only.
“We didn’t find significant differences between the two groups,” said Dr. Xie Qing, director of Ruijin’s infectious diseases department.
About 85.4 percent of patients with hydroxychloroquine tested negative for COVID-19, compared with 81.3 percent of the other group. The average symptom relief time for the first group was 19 days for the group with hydroxychloroquine and 21 days for the others.
Scientists noticed that the frequency of adverse reactions from taking hydroxychloroquine was 30%, which is much higher than 8.8% in the second group.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference
- First Armenian-German Conference entitled “Heart Failure Spring School”
- Allogeneic bone marrow transplant in case of hematological malignancy performed in Armenia for first time
All materials
- Archive
- Most read
month
week
day
- Scientists found baked goods and lack of sleep to be more dangerous than alcohol 1069
- Unhealthy amount of sugar found in baby food products of a well-known brand 998
- Air pollution puts health of more than 1.6 billion workers globally at risk 991
- 342 cases of measles recorded in Armenia so far in 2024 987
- Ketamine may help with postpartum depression 975
- Appetite: Scientists found out the secret to the appeal of large portions of fast food 973
- Scientists test new approach to fighting viruses 954
- Zombie deer disease possibly linked to hunters’ deaths 932
- Cognitively stimulating jobs in midlife could lower dementia risk in old age, study finds 849
- BrainStimulation: electrical brain stimulation alleviates anxiety and depression in the elderly 779
- Mpox epidemic declared in Republic of the Congo 717
- Paralyzed man in China writes hieroglyphs using neural implants placed in his brain 712
- JAMA: patient grew long, curly eyelashes because of chemotherapy 633
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference 623
- OU: quitting smoking 4 times more likely to cure laryngeal cancer 611
- Find us on Facebook
- Poll